Member Info for wadogara

..before the spelling police arrive...

Scaled up,staffed up..couple of quick succession Home Use Approvals and we'll have orders coming out of our ears.

Old news,once again over-dramatised,.but thanks again for your ongoing concern for OUR investments.

@Matthew.I didn't sell either,at or near the peaks.Difference is,i don't come on here moaning about "when will it ever deliver" etc. I take responsibility for my own decisions and i still believe there is huge upside from here.If it's too much for you then why not just take your 20% profit and invest elsewhere ?..greedy for more ?

..and someone else moaning earlier about their 20p average.."when will this ever deliver?"..or something to that effect. Em..so a 5-bagger when the SP was over £1 would not be described as delivering ?!...look within,i have a feeling personal greed may have clouded your judgement.

"down to only 20% profit"..poor you Matthew.So you were obviously further ahead at various stages but chose not to cash in any..prob Colin's fault as well i suppose.Many here wouldn't mind being in the black at all..twit.

The sweet scent of HUA beginning to fill the air. Once the change-over from PCR to LFT really kicks in we're sky bound.RNS imminent.

.

Think u need a coffee there StarKnight

Hi Reg..TB also tied with CMH,another manufacturing outfit.Who knows with TB,.enigma.

I see Stonehage Fleming Investment Ltd also upped their investment in Velocity,.twice in July,.now holding over 11%.Something brewing.

GC just bought more - 100,000 @52p

https://twitter.com/Abingdon_Health/status/1442422011704217609

Blu..if you were so deterred by what has gone before you would not still be here.

Btw..no need to highlight the "Assuming full uptake"..like i said,even at 33% uptake we're looking at a rerate.

We've all been through the ups and downs.What's been has passed.I still see this as having strong upside potential considering the incoming demand for LFTs worldwide..that's why i'm still here and that's why i don't keep looking back,moaning about the mistakes that have been made.

Re tweet from Shredz,.let's not glance over these estimates / projections.
Assuming full uptake of 2mn p/wk capacity,split between our own Visitect,Antibody and DHSC contract tests, :
Gross Profit,PER WEEK,of over £4mn (assuming 50% margin on all tests)
Revenue,per year circa £450mn
Gross Profit,per year (assuming 30% margin on DHSC Contract and 50% on the rest)..£186mn

Let's be really,really conservative and assume 33% take up of current full capacity,GP per year approx. £60mn.
Considering both the UK and US ran short of LFT supplies during the week,considering they have yet to be green lighted to complement/largely replace PCRs for air travel (150- 180mn passengers per year in/out of UK pre-covid)..is a mere 33% utility/uptake really that unattainable from the position we're now in ?..a mere £60mn Gross Profit. 50% uptake then we're looking at approx.£90mn GP. Current mcap well below £100mn..seriously undervalued.Surely just a matter of time and confirmation of what we already know now before this rerates.Looking forward to the next couple of weeks,BIG news coming our way.GLA and hold tight.The trolls on here aren't here for your benefit or mine.

Thanks again Blue..sorry for putting you in the firing line on a Friday night lol..much appreciated.

Thks Blu.So it's not a waste of money buying these,soon to be old,Tils shares at these prices..i.e.old Tils will turn into half the number of new Tils,whose SP will follow in line with that of TLSA..and i can then sell my new Tils in the future,hopefully when they re-rate higher..yes?

Sorry guys,seeking clarification again if possible.After the 21st Oct.,for anyone still holding shares in Tils..will Tils share price here follow in line with that of Tlsa stateside,.even though we can only sell them on this side of the pond ?.or will the share price here just gradually fall with sells only and no buys ?..sorry,want to double check this novel situation before i buy any more...